Images: Pfizer, FDA Pfizer recalled one of its hypertension-treating drugs after it was found to have an increased presence of an impurity that can cause cancer.
Five lots of Accupril (Quinapril HCl) tablets have been recalled due to a presence of a nitrosamine above the acceptable daily intake level.
Increased intake of nitrosamines can increase the risk of cancer over long periods of time. Those currently taking the affected Accupril tablets are not at any immediate risk and Pfizer is not aware of reports of adverse events related to the recall.
The product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from December 2019 to April 2022.The included tablets in the recall all come in 90 count bottles with strengths of 10 mg, 20 mg and 40 mg.